Medicine Demand ECHS RE 03 - Department of Defence

ACEBROPHYLLINE 100 MG TAB,ANASTRAZOLE 1 MG TAB,ASCORBIC ACID 500 MG TAB VIT C,BUDESONIDE 200 MCG RO

Goods
Qty:6L

Tender Timeline

Tender Issue
May 28, 2025 at 1:13 PM

Tender Title: Medicine Demand ECHS RE 03

Reference Number: 1cf5cc27f

Issuing Authority: Department of Defence, Ministry of Defence

The Medicine Demand ECHS RE 03 tender invites bids for the procurement of a wide range of essential medicines required for the Ex-Servicemen Contributory Health Scheme (ECHS). This initiative seeks to ensure the availability of quality healthcare services for veterans and their dependents across various facilities. The key objective is to secure a consistent supply of high-quality pharmaceutical products in compliance with the applicable regulations and standards.

Scope of Work and Objectives

The scope of work encompasses the supply of medicinal products including but not limited to:

  • ACEBROPHYLLINE 100 MG TAB
  • ANASTRAZOLE 1 MG TAB
  • ASCORBIC ACID 500 MG TAB (Vitamin C)
  • BUDESONIDE 200 MCG ROTACAP
  • Various other medications including pain relief, antibiotics, and other critical healthcare drugs.

The primary objective of this tender is to achieve timely delivery and distribution of the total quantity of 598,279 medicinal units as specified in the bid documentation. Successful bidders must ensure that all products adhere to the necessary regulatory frameworks and quality standards.

Eligibility Criteria

Eligible bidders must be registered entities specializing in pharmaceutical supply. This includes manufacturers, authorized dealers, and distributors who fulfill specific performance and compliance standards set forth in the tender documents. Interested parties should demonstrate their capability to deliver the required products effectively and efficiently.

Technical Requirements

Bidders are required to meet specific technical specifications concerning the formulation, quality, and packaging of the medicines. All products must comply with the guidelines established by the regulatory authorities governing the pharmaceutical sector. Necessary certifications and documentation proving compliance with quality standards must be submitted along with the bid.

Financial Requirements

Financially, bidders should provide evidence concerning their financial stability and ability to fulfill the contract terms. This may include recent financial statements, payment history, and any other relevant documentation that demonstrates the bidder's financial viability.

Document Submission Details

Bids must be submitted electronically through the designated tender platform by completing all required fields and attaching the necessary documents. Accurate documentation submission is vital for the evaluation process, and any discrepancies may lead to disqualification.

Special Provisions

This tender includes provisions to encourage participation from Micro, Small, and Medium Enterprises (MSEs) and startups. Specific benefits may be outlined to facilitate their involvement in the tender process, providing preferential treatment in terms of evaluation and contract awarding.

Evaluation Process

The evaluation process will be transparent and systematic. Bids will be assessed based on parameters such as compliance with eligibility criteria, technical specifications, financial stability, and overall pricing. The selection committee will review all submissions, ensuring that the awarded bid aligns with the best value for the government entity.

Delivery Locations

Successful bidders will be required to deliver the products to designated health facilities outlined in the tender documents. Adherence to the delivery schedule is critical, and bidders must possess the logistical capabilities to meet the outlined timelines.

Contact Information

For any inquiries or additional information regarding the tender, please refer to the official communication channels provided on the tender portal.


Tender BOQ Items

29 Items
1.

ACEBROPHYLLINE 100 MG TAB

Qty:7200
Unit:no
30
2.

ANASTRAZOLE 1 MG TAB

Qty:2400
Unit:no
30
3.

ASCORBIC ACID 500 MG TAB VIT C

Qty:15000
Unit:no
30
4.

BUDESONIDE 200 MCG ROTACAP

Qty:1800
Unit:no
30
5.

CALCIUM CARBONATE 500 MG and Vit D3 TAB

Qty:472000
Unit:no
30
6.

CILNIDIPINE 5 MG TAB

Qty:3000
Unit:no
30
7.

CLINDAMYCIN 1 Percentage GEL 10 GM

Qty:120
Unit:no
30
8.

DEXAMETHASONE 4MG TAB

Qty:3400
Unit:no
30
9.

DICLOFENAC SPRAY BOTTLE OF 35 GM

Qty:2700
Unit:bott
30
10.

ED CIPROFLOXACIN AND DEXAMETHASONE

Qty:1470
Unit:bott
30
11.

ED NEPAFENAC 0 POINT 1 PERCENTAGE W PER V

Qty:550
Unit:bott
30
12.

FLUOXETINE 20MG TAB

Qty:8500
Unit:no
30
13.

FOLEYS CATHETER 2 WAY SIZE 18 FR

Qty:260
Unit:no
30
14.

INJ CIPROFLOXACIN 200 MG PER 100 ML

Qty:95
Unit:bott
30
15.

INJ DULAGLUTIDE 0.75 MG

Qty:24
Unit:pfs
30
16.

INSULIN PREMIXED BIPHASIC A 40 IU PER ML 30 PERCENTAGE HUMAN NEUTRAL PLUS 70 PERCENTAGE HUMAN ISOPHANE INSULIN 10 ML INJ

Qty:1780
Unit:vial
30
17.

KETORALAC 0 PONT 2 PERCENTAGE EYE DROP

Qty:470
Unit:bott
30
18.

MESALAMINE 1 GM SACHET

Qty:240
Unit:sachet
30
19.

METHOTREXATE 7 PONT5 MG TAB

Qty:6000
Unit:no
30
20.

NORFLOXACIN 400MG AND TINIDAZOLE 600MG TAB

Qty:2400
Unit:no
30
21.

OFLOXACIN 0 POINT 3 PERCENTAGE BOTT OF 5 ML

Qty:320
Unit:bott
30
22.

POVIDONE IODINE SOLUTION 5 PERCENTAGE BOTTLE OF 100 ML

Qty:1050
Unit:bott
30
23.

PRAZOSIN SR 5 MG TAB

Qty:8500
Unit:no
30
24.

SCALP VEIN SET

Qty:720
Unit:no
30
25.

SILVER SULFADIAZINE OINT

Qty:80
Unit:tube
30
26.

TAURINE 500 MG AND ACETYLCYSTINE 150 MG

Qty:47400
Unit:no
30
27.

THIOCOLCHICOSIDE 8 MG TAB

Qty:10200
Unit:no
30
28.

VALCIVIR 500 MG TAB

Qty:540
Unit:no
30
29.

INSULIN HIGHLY PURIFIED ISOPHANE HUMAN NPH 40 IU PER ML 10 ML INJ

Qty:60
Unit:vial
30

General Information

Item Category
ACEBROPHYLLINE 100 MG TAB , ANASTRAZOLE 1 MG TAB , ASCORBIC ACID 500 MG TAB VIT C , BUDESONIDE 200 MCG ROTACAP , CALCIUM CARBONATE 500 MG and Vit D3 TAB , CILNIDIPINE 5 MG TAB , CLINDAMYCIN 1 Percentage GEL 10 GM , DEXAMETHASONE 4MG TAB , DICLOFENAC SPRAY BOTTLE OF 35 GM , ED CIPROFLOXACIN AND DEXAMETHASONE , ED NEPAFENAC 0 POINT 1 PERCENTAGE W PER V , FLUOXETINE 20MG TAB , FOLEYS CATHETER 2 WAY SIZE 18 FR , INJ CIPROFLOXACIN 200 MG PER 100 ML , INJ DULAGLUTIDE 0.75 MG , INSULIN PREMIXED BIPHASIC A 40 IU PER ML 30 PERCENTAGE HUMAN NEUTRAL PLUS 70 PERCENTAGE HUMAN ISOPHANE INSULIN 10 ML INJ , KETORALAC 0 PONT 2 PERCENTAGE EYE DROP , MESALAMINE 1 GM SACHET , METHOTREXATE 7 PONT5 MG TAB , NORFLOXACIN 400MG AND TINIDAZOLE 600MG TAB , OFLOXACIN 0 POINT 3 PERCENTAGE BOTT OF 5 ML , POVIDONE IODINE SOLUTION 5 PERCENTAGE BOTTLE OF 100 ML , PRAZOSIN SR 5 MG TAB , SCALP VEIN SET , SILVER SULFADIAZINE OINT , TAURINE 500 MG AND ACETYLCYSTINE 150 MG , THIOCOLCHICOSIDE 8 MG TAB , VALCIVIR 500 MG TAB , INSULIN HIGHLY PURIFIED ISOPHANE HUMAN NPH 40 IU PER ML 10 ML INJ
Ministry Name
Department Name

Financial Information

OEM Average Turnover
₹50.00 Lakh (s)
Minimum Turnover
₹10.00 Lakh (s)
Bid Offer Validity
90 (Days)
Past Performance
60 %
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Total value wise evaluation
RA Qualification Rule
50% Lowest Priced Technically Qualified Bidders
Inspection Required
Yes
Technical Clarifications Time
2 Days

Tender Documents

4 Documents
GeM-Bidding-7886814.pdfMain Document
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Documents Required from Seller

  • Experience Criteria
  • Past Performance
  • Bidder Turnover
  • Certificate (Requested in ATC)
  • OEM Authorization Certificate
  • OEM Annual Turnover
  • Additional Doc 1 (Requested in ATC) *In case any bidder is seeking exemption from Experience / Turnover Criteria
  • the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Similar Tenders

View All

Morphine 15 mg, 1 ml Inj,Pethedine 50 mg, 1 ml Inj,Tramadol HCl 50 mg Cap or Tab,Clonazepam 2 mg Ta

GEM
Goods
Qty:4.5L
4 Files
Indian Army
Boq › Boql
Morphine 15 mg, 1 ml Inj , Pethedine 50 mg, 1 ml Inj , Tramadol HCl 50 mg Cap or Tab , Clonazepam 2 mg Tab , Clotrimazole mouth paint 1 percent bottle of 15 ml , Tranexamic Acid 500 mg per 5ml Inj , Antiseptic mouth wash containing Sodium fluoride and triclosan bott of 100 ml , Benzocaine 20 percent, Pectin based, oral ointment Tube of 5 gm , Adapalene 0.1 percent Tube of 15 gm , Benzoyl Peroxide 2.5 percent Tube of 20 gm , Antispasmodic Tab containing Mefenamic Acid 250 mg and Dicyclomine HCl 10 mg , Metoclopramide syrup 5mg percent 5ml bott of 30 ml , Isapgol or Ispaghula husk 3.5 gm , Loperamide 2mg Tab , Gentamicin sulphate 0.3 percent w per v gentamicin base with Hydrocortisone acetate IP 1 percent w per v eye and ear drops bott of 5 ml , Cinnarizine 25 mg Tab , Clotrimazole 1 percent w per v IP plus Lignocaine 2 percent w per v IP ear drop, bott of 10ml , Nasal Decongestant adult drops, Xylometazoline HCl 0.1 percent w per v nasal drop bottle of 10 ml , Metronidazole susp 200 mg per 5ml bott of 60 ml , Alprazolam 0.25 mg Tab , Sterile water, amp of 10 ml , Anti phlebitis cream Tube of 15 g or 20 g , Glucosamine 500 mg Tab , Antacid chewable containing dried Aluminium Hydroxide IP 250 mg, Mag Hydroxide NF 250 mg, Methyl Polysiloxane 50 mg Tab , Hepatitis B Vaccine 10 ml , Glucose saline isotonic solution in non toxic disposable plastic bott of 500ml FFS , Adjustable arm pouch sling size L or M or S , Heel Cup, Silicon or Carbon Copolymer , Cough sedative syp, each 5 ml containingChlorpheniramine maleate 2.5mg, Guaiphenesin 100mg, Noscapine 15mg, Sodium citrate 60mg in flavoured base, bott of 100 ml
May 30, 2025
June 21, 2025 at 11:00 AM
View Details

Frequently Asked Questions

The eligibility requirements include being a registered entity in the pharmaceutical industry, and demonstrable experience in the supply of medicinal products. Bidders must comply with local regulations governing pharmaceuticals, and also possess necessary certificates and licenses to operate within this sector. Statutory compliance, including tax and labor regulations, must be met to qualify.

Bidders must ensure that the products align with the defined technical specifications which may include formulation potency, shelf-life, and packaging requirements. Compliance with local and international quality standards is mandatory, and all products should have relevant documentation certifying their suitability for medical use. This ensures that all medicines supplied maintain high standards of safety and efficacy.

The Earnest Money Deposit (EMD) is a monetary assurance required from bidders, securing their commitment to the tender process. The amount of EMD required and its terms will be detailed within the tender documentation. Failure to submit the EMD will result in disqualification. Additionally, understanding the conditions for performance security is crucial for finalizing the contract terms.

Bidders must submit their offers electronically via the tender platform set out by the Ministry of Defence. All documents must be uploaded in the specified accepted document formats outlined in the tender guidelines, ensuring that submissions conform to file size limits and necessary file types such as PDFs or DOCX.

There are specific provisions encouraging the participation of Micro, Small, and Medium Enterprises (MSEs), which may include simplified qualification requirements and additional benefits during the evaluation. These support measures align with initiatives such as the ‘Make in India’ policy, promoting local manufacturing and procurement. MSEs may also receive preferential evaluations enhancing their chances of being awarded the contract.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders